Clinical Trials Directory

Trials / Completed

CompletedNCT01854242

Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease

Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease: A New Comorbidity or Secondary Consequence

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this research study is to understand the relationship between inflammatory bowel disease (IBD) and Glycogen storage disease (GSD)type Ia. GSD type Ib has been established to have an association with IBD with clinical and histologic features that mirror those of Crohn disease. Development of the disease seems to be related to the defect of neutrophil function in individuals with GSD type Ib and subsequent colonic inflammation. In the last decade, it has become a standard for patients with GSD type Ib and gastrointestinal symptoms to be evaluated for IBD. Patients with GSD type Ia were not recognized to have similar gastrointestinal symptoms until recently. The prevalence of IBD is greater in patients with GSD type Ia versus the general population.

Detailed description

The purpose of this research study is to understand the relationship between IBD and GSD type Ia. The Investigators will be attempting to develop a blood test which will be aimed at the participants diagnosis of IBD. As a participant in this research study, a blood sample will be collected during your admission to the University of Florida. This will not affect the length of stay of your scheduled visit. There will be no scheduled clinic follow-up.

Conditions

Interventions

TypeNameDescription
OTHERGlycogen Storage Disease type Ia patientsThe participants will have one blood draw for this study. The test will be performed on the blood.

Timeline

Start date
2013-11-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2013-05-15
Last updated
2020-07-28
Results posted
2014-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01854242. Inclusion in this directory is not an endorsement.